The KDIGO guidelines [11] recommend the estimation of GFR based on serum cystatin C in adult patients with suspected stage G3a of chronic kidney disease (GFR between 45 and 60 ml/min/1.73 m2). This evidence concerns the gene CST3 and chronic kidney disease.